Impact of chemotherapy on survival in surgically resected retroperitoneal sarcoma.

@article{Miura2015ImpactOC,
  title={Impact of chemotherapy on survival in surgically resected retroperitoneal sarcoma.},
  author={John T. Miura and John A. Charlson and T Clark Gamblin and Dan C. Eastwood and Anjisnu Banerjee and Fabian M Johnston and Kiran K. Turaga},
  journal={European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology},
  year={2015},
  volume={41 10},
  pages={1386-92}
}
BACKGROUND The role of systemic chemotherapy (CT) in the multimodality treatment strategy for retroperitoneal sarcomas (RPS) remains controversial. We hypothesized that chemotherapy does not improve overall survival for patients with surgically resected RPS. METHODS The National Cancer Database was used to identify all patients with RPS that underwent surgical resection from 1998 to 2011. Univariate and multivariable Cox proportional hazards modeling were used to assess overall survival (OS… CONTINUE READING